These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29229320)

  • 1. Vaccine-mismatched influenza B/Yamagata lineage viruses in Cuba, 2012-2013 season.
    Arencibia A; Piñón A; Acosta B; Fernandez L; Muné M; Valdés O; Savón C; Oropesa S; Gonzalez G; Roque R; Gonzalez G; Hernández B; Alfonso JM
    Infect Genet Evol; 2018 Mar; 58():110-114. PubMed ID: 29229320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017.
    Puzelli S; Di Martino A; Facchini M; Fabiani C; Calzoletti L; Di Mario G; Palmieri A; Affanni P; Camilloni B; Chironna M; D'Agaro P; Giannecchini S; Pariani E; Serra C; Rizzo C; Bella A; Donatelli I; Castrucci MR;
    BMC Infect Dis; 2019 Nov; 19(1):990. PubMed ID: 31752738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Noh JY; Choi WS; Song JY; Lee HS; Lim S; Lee J; Seo YB; Lee JS; Wie SH; Jeong HW; Heo JY; Kim YK; Park KH; Kim SW; Lee SH; Lee JH; Kim DH; Woo SI; Lim CS; Cho KS; Cheong HJ; Kim WJ
    Vaccine; 2018 Aug; 36(35):5304-5308. PubMed ID: 30057284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza B Viruses in the Population of Province of Vojvodina during the 2012/2013 Season: Differentiation of B/Yamagata and B/Victoria Lineages by Real-time RT-PCR, Antigenic and Phylogenetic Characterization.
    Radovanov J; Milošević V; Cvjetković IH; Ristić M; Djilas M; Nikolić N; Patić A; Kovačević G; Galović AJ; Petrović T; Mikić SS
    Srp Arh Celok Lek; 2015; 143(7-8):429-37. PubMed ID: 26506753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Virological characterization of influenza B virus in mainland China during 2011-2012].
    Huang WJ; Tan MJ; Lan Y; Cheng YH; Wang Z; Li XY; Guo JF; Wei HJ; Chen YY; Xiao N; Liu B; Sui HT; Zhao X; Wang DY; Shu YL
    Bing Du Xue Bao; 2013 Jan; 29(1):32-8. PubMed ID: 23547377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic and genomic characterization of human influenza A and B viruses circulating in Argentina after the introduction of influenza A(H1N1)pdm09.
    Russo ML; Pontoriero AV; Benedetti E; Czech A; Avaro M; Periolo N; Campos AM; Savy VL; Baumeister EG
    J Med Microbiol; 2014 Dec; 63(Pt 12):1626-1637. PubMed ID: 25351708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B; Neri M; Lepri E; Iorio AM
    Vaccine; 2009 Jun; 27(31):4099-103. PubMed ID: 19410623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debate on the compositions of influenza B in northern hemisphere seasonal influenza vaccines.
    He G; Yang P; Yan Q; Xiong C
    Antimicrob Resist Infect Control; 2019; 8():164. PubMed ID: 31673353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of isolates from influenza B outbreaks in the U.S. and Nepal, 2005.
    Daum LT; Canas LC; Klimov AI; Shaw MW; Gibbons RV; Shrestha SK; Myint KS; Acharya RP; Rimal N; Reese F; Niemeyer DM; Arulanandam BP; Chambers JP
    Arch Virol; 2006 Sep; 151(9):1863-74. PubMed ID: 16736092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
    Broberg E; Melidou A; Prosenc K; Bragstad K; Hungnes O;
    Euro Surveill; 2016; 21(13):. PubMed ID: 27074657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
    Skowronski DM; Chambers C; De Serres G; Dickinson JA; Winter AL; Hickman R; Chan T; Jassem AN; Drews SJ; Charest H; Gubbay JB; Bastien N; Li Y; Krajden M
    Euro Surveill; 2018 Feb; 23(5):. PubMed ID: 29409570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and genetic characterization of influenza B virus in Lebanon during 2016-2018.
    AlIbrahim M; Assaf-Casals A; Massaad E; Shaker R; Soudani N; Fayad D; Chamseddine S; Lteif-Khoury M; Chmaisse A; Isaac I; Anan H; Sadaka C; Radwan N; Ghanem S; Naous A; Karam M; Andary R; Dbaibo G; Zaraket H
    Infect Genet Evol; 2019 Nov; 75():103969. PubMed ID: 31325610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005.
    Tsai HP; Wang HC; Kiang D; Huang SW; Kuo PH; Liu CC; Su IJ; Wang JR
    J Clin Microbiol; 2006 Aug; 44(8):2705-13. PubMed ID: 16891481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic and genomic relation between human influenza viruses that circulated in Argentina in the period 1995-1999 and the corresponding vaccine components.
    Pontoriero AV; Baumeister EG; Campos AM; Savy VL; Lin YP; Hay A
    J Clin Virol; 2003 Oct; 28(2):130-40. PubMed ID: 12957183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons.
    Puzelli S; Frezza F; Fabiani C; Ansaldi F; Campitelli L; Lin YP; Gregory V; Bennett M; D'Agaro P; Campello C; Crovari P; Hay A; Donatelli I
    J Med Virol; 2004 Dec; 74(4):629-40. PubMed ID: 15484280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular influenza surveillance at a tertiary university hospital during four consecutive seasons (2012-2016) in Catalonia, Spain.
    Andrés C; Peremiquel-Trillas P; Gimferrer L; Piñana M; Codina MG; Rodrigo-Pendás JÁ; Campins-Martí M; Carmen Martín M; Fuentes F; Rubio S; Pumarola T; Antón A
    Vaccine; 2019 Apr; 37(18):2470-2476. PubMed ID: 30926297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].
    de Jong JC; Rimmelzwaan GF; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2007 Sep; 151(39):2158-65. PubMed ID: 17957994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017.
    Palekar R; Rodriguez A; Avila C; Barrera G; Barrera M; Brenes H; Bruno A; El Omeiri N; Fasce R; Ferreira de Almeida W; Franco D; Huaringa M; Lara J; Loayza R; Lopez-Martinez I; Maria de Paiva T; Medina J; Ojeda J; Ropero AM; Sotomayor V; Vazquez C; Von Horoch M
    PLoS One; 2019; 14(8):e0219595. PubMed ID: 31393886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.